Scott Hensley

Advisers to the Food and Drug Administration voted 20-0 to recommend that the agency authorize Moderna's vaccine for emergency use during the pandemic. There was a single abstention.

In a 17-4 vote, an expert committee concluded that the scientific evidence supports the authorization of the COVID-19 vaccine from Pfizer and BioNTech for emergency use during the pandemic.

How do Americans experience and cope with pain that makes everyday life harder? We asked in the latest NPR-IBM Watson Health Poll.

The latest NPR-IBM Watson Health poll found that 29% of people said they were often angry when checking the news. Another 42% said the news sometimes made them angry.

The latest NPR-IBM Watson Health Poll finds that medical visits for symptoms of infections are common and that many people get an antibiotic under those circumstances. But a talk is in order first.

A third of people under 35 said cost led them to put off some form of health care, compared with only 8 percent of people 65 and older, a poll by NPR and IBM Watson Health found.

While a majority of Americans know about naloxone, there is confusion about the fact that in most places a prescription isn't required to obtain the emergency overdose treatment.

A surgeon at Brigham and Women's Hospital in Boston, Gawande is probably best known for his work writing about how to improve quality and lower costs in health care .

We asked Americans about genetic testing in the latest NPR-Truven Health Analytics Health Poll. People were generally OK with sharing the information with relatives and doctors, but not employers.

Journalists from Kaiser Health News and NPR will be looking at surprising medical bills and figuring out what they can tell us about the health care system. You can share your story here.

Details are scarce, but the companies said they want to help their employees get high-quality health care at a reasonable cost. Will this consortium have better luck than those that have preceded it?

A July letter from Aetna CEO Mark Bertolini to the Justice Department said the company would pull back from health insurance exchanges if the government opposed the company's merger with Humana.